Corcept Therapeutics Incorporated (FRA:HTD)

Corcept Therapeutics Statistics

Total Valuation

FRA:HTD has a market cap or net worth of EUR 7.22 billion. The enterprise value is 6.77 billion.

Market Cap	7.22B
Enterprise Value	6.77B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.19M
Shares Outstanding	n/a
Shares Change (YoY)	+7.55%
Shares Change (QoQ)	-0.87%
Owned by Insiders (%)	11.43%
Owned by Institutions (%)	68.65%
Float	86.99M

Valuation Ratios

The trailing PE ratio is 80.93 and the forward PE ratio is 68.34.

PE Ratio	80.93
Forward PE	68.34
PS Ratio	11.43
PB Ratio	13.40
P/TBV Ratio	13.40
P/FCF Ratio	51.93
P/OCF Ratio	51.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 113.27, with an EV/FCF ratio of 48.73.

EV / Earnings	75.93
EV / Sales	10.62
EV / EBITDA	113.27
EV / EBIT	120.08
EV / FCF	48.73

Financial Position

The company has a current ratio of 3.14, with a Debt / Equity ratio of 0.01.

Current Ratio	3.14
Quick Ratio	2.85
Debt / Equity	0.01
Debt / EBITDA	0.09
Debt / FCF	0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.70% and return on invested capital (ROIC) is 6.38%.

Return on Equity (ROE)	16.70%
Return on Assets (ROA)	5.10%
Return on Invested Capital (ROIC)	6.38%
Return on Capital Employed (ROCE)	10.07%
Revenue Per Employee	1.26M
Profits Per Employee	178,397
Employee Count	500
Asset Turnover	0.92
Inventory Turnover	1.31

Taxes

Income Tax	-15.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+22.91%
50-Day Moving Average	67.14
200-Day Moving Average	62.63
Relative Strength Index (RSI)	55.76
Average Volume (20 Days)	20

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.29

Income Statement

In the last 12 months, FRA:HTD had revenue of EUR 631.70 million and earned 89.20 million in profits. Earnings per share was 0.74.

Revenue	631.70M
Gross Profit	620.29M
Operating Income	55.89M
Pretax Income	75.44M
Net Income	89.20M
EBITDA	56.86M
EBIT	55.89M
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 359.40 million in cash and 5.42 million in debt, giving a net cash position of 441.39 million.

Cash & Cash Equivalents	359.40M
Total Debt	5.42M
Net Cash	441.39M
Net Cash Per Share	n/a
Equity (Book Value)	538.57M
Book Value Per Share	5.12
Working Capital	314.38M

Cash Flow

In the last 12 months, operating cash flow was 139.25 million and capital expenditures -240,349, giving a free cash flow of 139.01 million.

Operating Cash Flow	139.25M
Capital Expenditures	-240,349
Free Cash Flow	139.01M
FCF Per Share	n/a

Margins

Gross margin is 98.19%, with operating and profit margins of 8.85% and 14.32%.

Gross Margin	98.19%
Operating Margin	8.85%
Pretax Margin	11.94%
Profit Margin	14.32%
EBITDA Margin	9.00%
EBIT Margin	8.85%
FCF Margin	22.01%

Dividends & Yields

FRA:HTD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.55%
Shareholder Yield	-7.55%
Earnings Yield	1.24%
FCF Yield	1.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:HTD has an Altman Z-Score of 24.03 and a Piotroski F-Score of 5.

Altman Z-Score	24.03
Piotroski F-Score	5